8 August 2019
(Applications close – 18 August)
We have an exciting opportunity available for a Research Scientist to join our Antibody Technologies Group on a 12-month fixed-term maternity leave cover. Based in our Research Department at the Bio21 Institute in Parkville, you will apply high quality molecular biology skills in the specialist area of recombinant antibody technologies, focusing on the selection from phage display human antibody libraries and protein engineering of recombinant antibodies. Under the guidance of senior members of the group you will become a key player in the optimisation of lead antibody drug candidates for human diseases with high, unmet medical needs.
It is the successful candidate’s responsibility to:
To be successful
The applicant must possess the following qualifications and skills:
CSL Limited is a company that fosters a work culture emphasizing Superior Performance, Innovation, Integrity, Collaboration and Customer Focus with a commitment to support, train and grow its people. As a genuine leader in the biopharmaceutical industry, CSL is a multinational ASX Listed Company that is actively growing its Australian based manufacturing operations to support global growth. CSL develops, manufactures and markets products to treat and prevent serious human medical conditions and is globally one of the largest manufacturers of plasma-derived therapies.
Applications must address the selection criteria above and include a current CV and covering letter.
Applications close Sunday 18th August 2019. Please apply via: Research Scientist, Antibody Technologies
Employment screening, including criminal history, medical assessment, confirmation of experience and stated qualifications, Australian working rights and other relevant checks form part of the candidate suitability evaluation process.